A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer
Clinical trial NCT05966584 · TERMINATED
Trial details
- NCT number
- NCT05966584
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2024-08-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.